"WO2009046824A2 - Use of apelin-12 as a therapeutic agent, eg for ...",https://www.google.com/patents/WO2009046824A2
EP1442528A2 - Decoding method and decoder for reed solomon ...,https://www.google.com/patents/EP1442528A2
WO2009046874A1 - Therapeutic combination of trh-potentiating ...,https://www.google.com/patents/WO2009046874A1?cl=pt
WO1998001740A2 - Diagnosis of williams syndrome and williams ...,https://www.google.com/patents/WO1998001740A2
CA2731204A1 - Use of a peptide as a therapeutic agent - Google ...,https://www.google.com/patents/CA2731204A1?cl=en
"WO2013186562A1 - Biomarkers for psychotic disorders, like ...",https://www.google.com/patents/WO2013186562A1
WO2009033747A2 - Use of a peptide as a therapeutic agent ...,https://www.google.com/patents/WO2009033747A2?cl=fi
US7892764B2 - System for seizure suppression - Google Patents,https://www.google.com/patents/US7892764
EP2187940B1 - Use of urocortin optionally together with ...,https://www.google.com/patents/EP2187940B1?cl=da
CA2698770A1 - Use of secretin and optionally urodilatin as a ...,https://www.google.com/patents/CA2698770A1?cl=ko
